Eid-Lidt G, Cortés-Lawrenz J, López-Cuellar J, Leiva-Pons JL, Alcocer-Gamba MA, Farjat-Pasos JI, García-Alcántara JA

Idioma: Inglés [English version]
Referencias bibliográficas: 22
Paginas: 209-216
Archivo PDF: 203.62 Kb.

FRAGMENTO

La enfermedad por coronavirus 2019 (COVID-19), causada por el nuevo coronavirus 2 del síndrome respiratorio agudo grave (SARS-CoV-2) fue descrita por primera vez a finales de 2019, se transformó rápidamente en una emergencia de salud pública y fue declarada pandemia por la Organización Mundial de la Salud (OMS) el 11 de marzo de 2020. El primer caso en nuestro país fue diagnosticado el 28 de febrero de 2020; sin embargo, para el día 16 de abril se estimaban ya 55,951 casos. Estas cifras traducen la alta transmisibilidad que este virus tiene entre los seres humanos, lo que representa una alta carga de morbimortalidad, así como un alto riesgo de contagio comunitario. Sin embargo, existe mayor riesgo de contagio entre los profesionales del área de la salud durante la atención de estos pacientes, sea en un triaje respiratorio, una terapia intensiva o una sala de cateterismo cardiaco.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Zhu N, Zhang DY, Wang WL, Li X, Yang B, Song J et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-733.

2. Coronavirus disease 2019 (COVID-19) Situation Report-51 [Internet]. World Health Organization. 11 de marzo de 2020. Disponible en: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports

3. Conferencia de prensa por COVID-19 del 28 de febrero de 2020 [Internet]. México: Secretaría de Salud, Gobierno de México; 28 de febrero de 2020. Disponible en: https://coronavirus.gob.mx/noticias

4. Conferencia de prensa por COVID-19 del 16 de abril de 2020 [Internet]. México: Secretaría de Salud, Gobierno de México; 16 de abril de 2020. Disponible en: https://coronavirus.gob.mx/noticias

5. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance 06 April 2020 [Internet]. World Health Organization; 6 de abril de 2020. Disponible en: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125

6. Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages. Interim guidance 06 April 2020 [Internet]. World Health Organization; 6 de abril de 2020. Disponible en: https://www.who.int/publications-detail/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages

7. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW et al.; American College of Cardiology’s (ACC) Interventional Council and the Society of Cardiovascular Angiography and Intervention (SCAI). Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC’s Interventional Council and SCAI. J Am Coll Cardiol. 2020 Mar 16. doi: 10.1016/j.jacc.2020.03.021. [Epub ahead of print]

8. Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X et al. CSC Expert consensus on principles of clinical management of patients with severe emergent cardiovascular diseases during the COVID-19 epidemic. Circulation. 2020 Mar 27. doi: 10.1161/CIRCULATIONAHA.120.047011. [Epub ahead of print]

9. Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN et al.; from the American College of Cardiology (ACC) and the Society for Cardiovascular Angiography and Interventions (SCAI). Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: An ACC/SCAI consensus statement. Catheter Cardiovasc Interv. 2020 Apr 6. doi: 10.1002/ccd.28910. [Epub ahead of print]

10. Gestión de salas de procedimientos invasivos cardiológicos durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación del Ritmo Cardiaco de la Sociedad Española de Cardiología [Internet]. Sociedad Española de Cardiología; 16 de marzo de 2020. Disponible en: https://secardiologia.es/blog/rec-interventional-cardiology/11449-covid-19-documento-de-consenso-gestion-de-salas-de-procedimientos-invasivos-cardiologicos-durante-el-brote-de-coronavirus-covid-19

11. Coronavirus disease (COVID-19) outbreak: rights, roles and responsibilities of health workers, including key considerations for occupational safety and health. Interim guidance 19 March 2020 [Internet]. World Health Organization; 19 de marzo de 2020. Disponible en: https://www. who.int/publications-detail/coronavirus-disease-(covid-19)-outbreak-rights-roles-and-responsibilities-of-health-workers-including-key-considerations-for-occupational-safety-and-health

12. Considerations in the investigation of cases and clusters of COVID-19. Interim guidance 13 March 2020 [Internet]. World Health Organization; 13 de marzo de 2020. Disponible en: https://www.who.int/who-documents-detail/considerations-in-the-investigation-of-cases-and-clusters-of-covid-19

13. Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19). Interim guidance 19 March 2020 [Internet]. World Health Organization; 19 de marzo de 2020. Disponible en: https://www.who.int/publications-detail/considerations-for-quarantine-of-individuals-in-the-context-of-containment-for-coronavirus-disease-(covid-19)

14. Advice on the use of masks in the context of COVID-19. Interim guidance 06 April 2020 [Internet]. World Health Organization; 6 de abril de 2020. Disponible en: https://www.who.int/publications-detail/advice-on-the-use- of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak

15. Critical preparedness, readiness and response actions for COVID-19. Interim guidance 19 March 2020 [Internet]. World Health Organization; 19 de marzo de 2020. Disponible en: https://www.who.int/publications-detail/critical-preparedness-readiness-and-response-actions-for-covid-19

16. Tarantini G, Fraccaro C, Chieffo A, Marchese A, Tarantino FF, Rigattieri S et al.; GISE. Italian Society of Interventional Cardiology (GISE) position paper for Cath lab-specific preparedness recommendations for healthcare providers in case of suspected, probable or confirmed cases of COVID-19. Catheter Cardiovasc Interv. 2020 Mar 29. doi: 10.1002/ccd.28888. [Epub ahead of print]

17. Morray BH, Gordon BM, Crystal MA, Goldstein BH, Qureshi AM, Torres AJ et al. Resource allocation and decision making for pediatric and congenital cardiac catheterization during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic: A U.S. multi-institutional perspective. J Invasive Cardiol. 2020; 32 (5): E103-E109.

18. Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet. 2020; 395 (10231): 1225-1228.

19. Tarantini G et al. The role of covid-19 protocol within a cardiology department. Presented at C3 and COVID19 Webinar Series - European Experience and Cardiology. C3 Interventional Academy. 2020 Apr 17. [Por ser publicado]

20. Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention; 14 de marzo de 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/clinical-criteria.html

21. Decontamination and Reuse of Filtering Facepiece Respirators [Internet]. Centers for Disease Control and Prevention; 9 de abril de 2020. Disponible en: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html

22. Fischer R, Morris D, Doremalen N et al. Assessment of N95 respirator decontamination and re-use for SARS-CoV-2 [Internet]. medRχiv; 24 de abril de 2020. Disponible en: https://www.medrxiv.org/content/10.1101/2020.04.11.20062018v2